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targeting the rRNA 18s gene (1, 2), were adopted for their optimal
performance. This study presents and discusses the results of the
use of RT-PCRs in conjunction with ELISA (VMRD, USA) and IFAT
(Fuller Laboratories, USA) that were used to analyse 274 horse
sera. For comparison of results, PCRwas used as reference method
since sequencing of derived amplicons conﬁrmed them as spe-
ciﬁc. The B. caballi RT-PCR detected 14 positive samples, none
conﬁrmed in ELISA, while the IFAT had a sensitivity (Se) of 50% (7/
14) and a speciﬁcity (Sp) of 87.7 % (228/260). The T. equi detected
137 positive samples with the ELISA showing a Se of 67.2% (92/
137) and an Sp of 83.2% (114/137) and the IFAT, a Se of 86.1% (118/
137) and an Sp of 81% (111/137). For both parasites, the IFAT
presented a limited major sensitivity when compared to the
ELISA. Results for B. caballi are preliminary as number of samples
recruited is limited. In particular, for T. equi the serological tests
showed a high agreement and a relatively high speciﬁcity. An
initial evaluation of the correlation between the PCR result and
clinical status of the animal was carried out deﬁning as cases
those presenting an EP acute form based on temperature >38C
and at least one of the following signs, jaundice, anaemia, and
petechial haemorrhages together with a PCR positive result. Of
the PCR positive horses for B. caballi and T. equi, only 28.7% and
19.7% respectively were deﬁned as cases, possibly due to parasite
persistence beyond the acute form. Seropositve results of PCR
negative samples could be due to sterilization of infected horses,
occurring spontaneously or following treatment with a longer
persistence of antibodies as usually occurs in most infections. An
additional value of the use of quantitative PCR is that treatment
efﬁcacy may be monitored especially in view of the side effects
this possess. This study demonstrates that the simultaneous use
of PCR with serological tests increases the diagnostic probability
to deﬁne the sanitary state for EP for the purposes stated above
and underlines the need for revision of the prescribed diagnostic
tests for trade that should include more sensitive methods.
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Validation of alphavirus chimeras for diagnosis of
Eastern and Venezuelan equine encephalitis
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Eastern and Venezuelan equine encephalitis cause signiﬁcant
disease in both horses and humans.
Effective equine diagnostics (passive surveillance of cases with
compatible clinical syndromes) can serve as advance warning for
human illnesses. In Central and South America, there are serious
difﬁculties in obtaining quality reagents for EEE and VEE di-
agnostics (per Dr. Alfonso Clavijo, Pan American Health Organi-
zation (PAHO), personal communication). Utilizing the genome of
Sindbis virus (SINV), a relatively nonpathogenic human alphavi-
rus, as a vector, a chimeric SIND/VEE virus expressing all of the
structural proteins of the VEE TC-83 vaccine strain has been
developed (Paessler 2003,Wang 2007). The nonstructural protein
genes and cis-acting RNA genome elements from wild-type SINV
strain AR339, and the structural protein genes from either North
American EEEV strain FL93- 939, or from the naturally murine-
attenuated SA strain BeAr436087, are included in the SIND/EEE
chimeras. In collaboration with PAHO, MIDA, and the InstitutoGORGAS, the National Veterinary Services Laboratories have ac-
quired these Sindbis/Alphavirus chimeras from Dr. Scott Weaver
of the University of Texas Medical Branch to validate proposed
diagnostic assays. Validation of diagnostic tests that can be per-
formed at biosafety level-2 will be beneﬁcial for use in both the
United States and in other countries. Chimeric virus propagation
was performed. Direct comparison of the SIND/EEE chimera to
wild-type EEE virus was performed using OIE approved protocols
for EEE IgM Enzyme-linked Immunosorbent Assay (ELISA) and
Plaque Reduction Neutralization Test (PRNT). Testing was per-
formed utilizing sera from naturally infected horses, determined
to be positive by previous diagnostic testing. With the goal of
developing inexpensive, easily performed diagnostics, the chi-
meras were tested without inactivation, using the methods pre-
viously mentioned. Antigen at a 1:10 dilution provided
consistently valid results with varying concentrations of both
conjugate and serum. Additional testing of inactivated chimeras
will also be performed. In addition to the increased safety to
humans who are conducting the diagnostic testing, proposed use
of chimeric strains in diagnostics will improve the ability of North,
South and Central American laboratories to easily and inexpen-
sively detect infection in animals, thereby leading to improved
prevention of infection in both humans and other equids.
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Equine herpesvirus 5 (EHV-5) infection has recently been asso-
ciated with equine multinodular pulmonary ﬁbrosis in horses. To
more completely understand EHV-5 pathogenesis and determine
viral and host contributions, further in vivo and in vitro studies are
needed. However, current techniques are unable to rapidly, spe-
ciﬁcally, and quantitatively characterize EHV-5 infection. The aim
of this project was to develop a TaqMan real-time PCR assay to
quantify EHV-5 in clinical and cell culture samples, and use this
test to describe viral replication over time in primary equine
respiratory epithelial cells (EREC)s. Primers and a probe were
designed to target gene E11 of EHV-5 for TaqMan real-time PCR.
Speciﬁcity was veriﬁed by testing multiple isolates of EHV-5, as
well as DNA from other equine herpesviruses. A plasmid con-
taining the target DNA was generated to create a standard curve
and quantify viral copy number. TaqMan real-time PCR was per-
formed on DNA isolated from clinical samples. In addition, ERECs
were inoculated with EHV-5, and cells and supernatants were
collected daily for 12 days following inoculation and TaqMan real-
time PCR was performed to asses EHV-5 infection and replication.
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S7eS19S12The developed TaqMan real-time PCR assay for EHV-5 detected
and quantiﬁed multiple currently circulating isolates of EHV-5,
while not detecting DNA from other equine herpesviruses,
including equine herpesvirus 2, a close homolog of EHV-5. Using
TaqMan real-time PCR, we were also able to quantify viral copy
number in EHV-5 inoculated ERECs over time and show signiﬁ-
cantly increased viral copies on days 5 and 6 post-inoculation that
declined sharply by day 12 post-inoculation. Quantiﬁcation was
not possible using conventional PCR. In conclusion, the developed
TaqMan real-time PCR assay is a rapid, speciﬁc, and sensitive test
that can be used to more accurately describe initial events
following EHV-5 infection and begin to understand viral patho-
genesis and establishment of latency. Furthermore, this assay will
be useful in future in vivo investigations to study the epidemi-
ology and pathogenesis of EHV-5 in its host.
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5ADIAGENE e, SAINT BRIEUC, FranceTaylorella equigenitalis is the causative agent of contagious
equine metritis (CEM). This venereal disease often originates
from a symptomless carrier and can spread rapidly in mares and
stallions. Isolation and identiﬁcation of T. equigenitalis is difﬁcult
due to a low growth rate, speciﬁc culture requirement and
limited differentiation from Taylorella asinigenitalis. Differentia-
tion of Taylorella species is essential as only T. equigenitalis has
been demonstrate to infect horses. Recovery of two others or-
ganisms implicated in equine metritis, Klebsiella pneumoniae and
Pseudomonas aeruginosa is also important. Rapid information
about the bacterial load measured by PCR method could be a
valuable tool for diagnosis and management of metritis. Most
PCR-based diagnostics are still considered time-consuming due
to disparate puriﬁcation, ampliﬁcation, and detection steps. Our
objective was to signiﬁcantly reduce sample preparation and
assay time. We have develop and evaluate a detection method
including a rapid preparation of the sample combined to two
real-time PCR assays for the detection of T. equigenitalis and T.
asinigenitalis in one hand, and K. pneumoniae and P. aeruginosa
in the other hand. Each PCR targets a gene speciﬁc for each
pathogen and contains an exogenous internal control. The vali-
dation of these two assays followed the AFNOR guideline NF
U47-600. 1) The analytical speciﬁcity, sensitivity and limit of
detection (LODPCR) were deﬁned for each real time PCR assays.
The analytical speciﬁcity of the PCR test was assessed on 99
different species that could be recovered from clinical samples
as well as 24 strains of T. equigenitalis, 14 of T. asinigenitalis, 33 of
K. pneumoniae and 16 of P. aeruginosa. LODPCR was determined
to be 5 genome equivalent (GE)/PCR reaction for T. equigenitalis
and 20 GE/PCR reaction for the others pathogens. 2) The whole
analytical process, from the lysis of the sample to the PCR
analysis, was characterised. Whole analytical process simply
consists in lysis of Amies charcoal swab emulsion directly ana-
lysed by PCR. LODMethod was determined as 100 and 7500 UFC/
mL according to the pathogen. Diagnostic sensitivity and spec-
iﬁcity of our solution are estimated from 500 Amies charcoal
swabs received directly from the ﬁeld. CEM organisms statuswere deﬁned by culture which is gold standard method. The
sensitivity of the overall method is 100% and the speciﬁcity is
greater than 92%. In conclusion, by eliminating sample puriﬁ-
cation before PCR analysis, we can provide a simple-to-use
method for the detection of pathogens implicated in equine
metritis and an alternative to culture during the breeding
season.
*AFNOR NF U47-600 norm: Requirements and recommendations
for the implementation, the development and the validation of
veterinary PCR for animal health analysis methods.
156
Dual antigen ELISA to differentiate infection from
vaccine antibody responses to Leptospira spp.
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Research in our laboratory and elsewhere has identiﬁed a
number of strongly immunogenic proteins of Leptospira inter-
rogans serovar Pomona type kennewicki (Lk) that are up-regu-
lated in infected horses but are undetectable or expressed only
in trace amounts on cultured organisms. Examples of these
proteins are Sph2 (Lk73.5), LigA and its truncate Lk90, Hsp15
and LipL45 (Qlp42). In contrast, the immunogenic LipL32 is
expressed abundantly on cultured L. interrogans serovar
Pomona type kennewicki and other serovars and elicits serum
antibody response in infected horses. Horses vaccinated with
heat-killed cultures of serovar Pomona type kennewicki would
therefore be predicted to make serum antibody responses to
LipL32 and Lk sonicate, but not to Sph2, LigA/Lk90, Hsp15 and
LipL45. The aim of this study was to develop an ELISA based on
LipL32 or Lk sonicate and one or more of the host-induced
proteins with value in differentiating vaccine serum antibody
responses from those induced by infection. Recombinant Sph2,
LigA, Lk90, Hsp15, LipL45 and LipL32 proteins of L. interrogans
serovar Pomona type kennewicki were expressed and puriﬁed
and antibody levels (IgG) speciﬁc for these proteins were
assayed in sera from horses (a) before and after immunization
with killed vaccine + adjuvant and b) infected naturally with L.
interrogans serovar Pomona type kennewicki. Sera diluted 1:200
were assayed in triplicate using optimum concentrations of re-
combinant proteins. Bound IgG was detected using HRP-Protein
G conjugate. Based on antibody responses of horses, reactive
proteins formed 3 groups, group 1 (Sph2, Lk90 and LigA) that
reacted strongly with convalescent sera but not with pre and
post vaccine sera; group 2 (LipL45 and Hsp15) that reacted
moderately with convalescent sera and at very low reactivity
with pre and post vaccine sera and group 3 (Lk sonicate and
LipL32) that reacted strongly with convalescent as well as post
vaccine sera but unreactive with pre vaccine sera. Antibodies to
Group 1 proteins were signiﬁcantly higher (p  0.01) in
convalescent sera than in pre and post vaccine sera. The
experimental vaccine based on L. kennewicki cultured in vitro
theoretically lacks expression of the host-induced proteins Sph2,
LigA and its truncate Lk90, LipL45 and Hsp15. As expected,
vaccine sera failed to react with these proteins. Signiﬁcantly
higher levels of antibody against constitutively expressed LipL32
and Lk sonicate in post vaccine sera as compared to pre vaccine
sera indicate horses responded well to the experimental vaccine.
A dual antigen ELISA based on Lk sonicate or LipL32 combined
with host-induced Sph2 and Lk90 proteins will be valuable in
differentiating responses of infected from vaccinated animals
(DIVA). However, differentiation of horses with recent previous
exposure to Leptospira that are subsequently vaccinated may
not be possible.
